Glaxo head, Andrew Witty, is in the news - this time he's bigging-up his company for being transparent.
Many of the mainstream press are carrying the story, "All Hail Sir Andrew". Critics are viewing this by asking their own questions, one such critic being Mickey Nardo, who, by his own admission, is one boring old man with time on his hands.
Mickey, a retired psychiatrist, raises some good points in a post here, he writes:
I don’t want to join the voices that find something wrong not matter what changes are made. So long as pharmaceutical manufacturers remain private business enterprises, we can expect the to act like other businesses in a capitalistic society. But at a time like this when GSK is making a change in policy towards something that needs fixing as badly as this does, I think it behooves us to go over it with a fine tooth comb to make sure it conforms to the needed change rather than represents another attempt at deceit. With GSK, we’ve earned the right to use that word [deceit] freely. I’ve already mentioned the issue of "panel of experts" as a potential conduit for deceit. But there’s something else.
